Hepatitis B Community
7.12k Members
Avatar universal


I just had an appointment with Dr. Gish - he said there is yet to be unreleased data from clinical trials showing GS 9620 has been effective, and non-toxic in escalating doses. He said things look very promising.  He also said clinical trials are still ongoing and they've relaxed the inclusion criteria, so others may be able to join (veteranB).

He also mentioned that ARC-520 will be doing first trials in Asia, then phase II trials in the USA.  He mentioned that ARC-520 may come to market sooner than Rep9AC', which he feels is still a long way away from coming to market.
19 Responses
Avatar universal
Very encouraging news, thanks.
Avatar universal
Praise to Allah ..
Avatar universal
Thanks DJ. I will email him.
Avatar universal
Am i missing something here?
Do we have any data on the clinical performances of these two compds even speculative in terms of success?
Avatar universal
They are still enrolling people in this trial, need to be HBV DNA Und to qualify.  They are looking to clear the surface antigen with GS9620
Avatar universal
@djxpress thanks for your response.
I guess to be undetected one has to be on Nuc's or had done intf in the past??
Am i correct?
The compds are designed for people that i currently on Nuc's treatment?
Have an Answer?
Didn't find the answer you were looking for?
Ask a question
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Here’s how your baby’s growing in your body each week.
These common ADD/ADHD myths could already be hurting your child
This article will tell you more about strength training at home, giving you some options that require little to no equipment.
In You Can Prevent a Stroke, Dr. Joshua Yamamoto and Dr. Kristin Thomas help us understand what we can do to prevent a stroke.
Smoking substitute may not provide such a healthy swap, after all.